No Data
Catalent (CTLT) Expands Its Facility Capabilities in Germany
Catalent Completes $25 Million Expansion of Its Clinical Supply Facility in Schorndorf, Germany
Expansion adds more temperature-controlled storage and dedicated space for FastChain demand-led supply service Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments
Catalent Price Target Maintained With a $63.50/Share by RBC Capital
Catalent Price Target Maintained With a $63.50/Share by RBC
RBC Capital Reiterates Sector Perform on Catalent, Maintains $63.5 Price Target
RBC Capital analyst Sean Dodge reiterates Catalent (NYSE:CTLT) with a Sector Perform and maintains $63.5 price target.
RBC Capital Maintains Catalent(CTLT.US) With Hold Rating, Maintains Target Price $63.5
RBC Capital analyst Sean Dodge maintains $Catalent(CTLT.US)$ with a hold rating, and maintains the target price at $63.5.According to TipRanks data, the analyst has a success rate of 39.3% and a
Analysts Conflicted on These Healthcare Names: Lantheus (LNTH) and Catalent (CTLT)